IDOX PLC

Director's Dealing • Mar 8, 2024

National Storage Mechanism | Additional information

RNS Number : 0794G

IDOX PLC

08 March 2024

8 March 2024

Idox plc 

("Idox", "the Company" or "the Group")

Director/PDMR Shareholding

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and Geospatial data solutions to the public and asset intensive sectors, announces that, on 7 March 2024, David Meaden, Chief Executive Officer of the Company, exercised nil cost options under the 2021 Idox plc Long Term Incentive Plan over a total of 622,640 ordinary shares of 1p each ("Ordinary Shares").

The Company also announces that, on the same day, Mr Meaden sold 294,000 Ordinary Shares at a price of 62.6p pence per share partially to satisfy current tax liabilities relating to option exercises over Ordinary Shares.

Following this notification, Mr Meaden has a beneficial holding of 1,439,179 Ordinary Shares (which represents 0.31% of the issued share capital of the Company).

Applications have been made for the 622,640 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 13 March 2024.

The total number of Ordinary Shares in issue following Admission will be 457,561,546. Therefore the total number of Ordinary Shares with voting rights in the Company will be 457,561,546.

The above figure of 457,561,546 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:

1.         

Details of the person discharging managerial responsibilities / person closely associated

a.         

Name

David Meaden

2.         

Reason for the notification

a.         

Position/status

Chief Executive Officer

b.         

Initial notification

/Amendment

Initial Notification

3.         

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.         

Name

Idox plc

b.         

LEI

213800Z3FE6PWVSUGE70

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.         

Nature of the transaction

1.   Exercise of options over Ordinary Shares

2.   Sale of Ordinary Shares.

c.         

Price(s) and volume(s)

	Price(s)	Volume(s)
1.	n/a	622,640
2.	62.6p	294,000

d.         

Aggregated information

·     Aggregated volume

·     Price  

	Price(s)	Volume(s)
1.	n/a	622,640
2.	62.6p	294,000

e.         

Date of the transaction

1.   7 March 2024

2.   7 March 2024

f.         

Place of the transaction

1.   Outside a trading venue

2.   London Stock Exchange (XLON); AIM

For further information please contact:

Idox plc  Chris Stone, Non-Executive Chairman David Meaden, Chief Executive Anoop Kang, Chief Financial Officer	+44 (0) 870 333 7101
Peel Hunt LLP (NOMAD and Broker) Paul Gillam Michael Burke Adam Telling	+44 (0) 20 7418 8900
MHP Communications   Reg Hoare Ollie Hoare Matthew Taylor	+ 44 (0) 203 128 8793 idox@mhpc.com

About Idox plc

For more information see  www.idoxplc.com  @Idoxgroup 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFFFFFVIIDIIS